Table 1. Characteristics of the subjects and expression of anti-NY-ESO-1 antibody.
| ICC (n = 103) | CHB (n = 108) | P | |
|---|---|---|---|
| Age (year) | 65.4 ± 13.4 | 62.7 ± 15.2 | 0.67 |
| Gender (female, %) | 69 (67.0) | 70 (64.8) | 0.28 |
| Smoking (n, %) | 54 (52.4) | 61 (56.5) | 0.49 |
| Alcohol drinking (n, %) | 46 (44.7) | 58 (53.7) | 0.07 |
| Anti-NY-ESO-1 (n, %) | 19 (18.4) | 4 (3.7) | <0.001 |
| Laboratory parameters | |||
| Anti-HBV (+) (n, %) | 49 (47.6) | 56 (51.9) | 0.49 |
| AFP (ng/ml) | 36.4 ± 13.1 | 7.1 ± 20.5 | <0.001 |
| T-Bil (μmol/L) | 124.9 ± 35.7 | 38.3 ± 12.2 | <0.001 |
| D-Bil (μmol/L) | 23.7 ± 36.2 | 15.6 ± 11.1 | <0.001 |
| AST (U/L) | 57.2 ± 11.2 | 66.2 ± 15.2 | 0.81 |
| ALT (U/L) | 54.2 ± 20.3 | 56.1 ± 37.3 | 0.79 |
| GGT (U/L) | 165.3 ± 435.2 | 162.2 ± 31.5 | 0.45 |
ICC: Intrahepatic cholangiocarcinoma; CHB: Chronic Hepatitis B.